FDAnews
www.fdanews.com/articles/187225-tilak-gains-ce-mark-approval-for-mobile-medical-videogame

Tilak Gains CE Mark Approval for Mobile Medical Videogame

June 14, 2018

Tilak received CE Mark approval for its therapeutic mobile videogame, Odysight, which triggers medical tests for follow-up of patients with chronic eye diseases.

The game, which is only available via prescription, monitors the evolution of visual parameters, such as near visual acuity, contrast sensitivity and the presence of scotomas or metamorphosis.

Using the medical mobile game app, the ophthalmologist can follow the patient in real time or during the consultation to track changes in the patient’s visual parameters through an online dashboard.

View today's stories